메뉴 건너뛰기




Volumn 22, Issue 6, 2017, Pages 749-753

Case report: Encephalitis, with brainstem involvement, following checkpoint inhibitor therapy in metastatic melanoma

Author keywords

[No Author keywords available]

Indexed keywords

B RAF KINASE; CD4 ANTIGEN; CD45 ANTIGEN; HLA DR ANTIGEN; HYDROCORTISONE; IPILIMUMAB; PEMBROLIZUMAB; MONOCLONAL ANTIBODY;

EID: 85020901007     PISSN: 10837159     EISSN: 1549490X     Source Type: Journal    
DOI: 10.1634/theoncologist.2016-0366     Document Type: Article
Times cited : (37)

References (22)
  • 1
    • 84929481481 scopus 로고    scopus 로고
    • Pembrolizumab versus ipilimumab in advanced melanoma
    • Robert C, Schachter J, Long GV et al. Pembrolizumab versus ipilimumab in advanced melanoma. N Engl JMed 2015;372:2521-2532.
    • (2015) N Engl JMed , vol.372 , pp. 2521-2532
    • Robert, C.1    Schachter, J.2    Long, G.V.3
  • 2
    • 84937759727 scopus 로고    scopus 로고
    • The Next Immune-Checkpoint Inhibitors: PD-1/PD-L1 Blockade in Melanoma
    • Mahoney KM, Freeman GJ, McDermott DF. The Next Immune-Checkpoint Inhibitors: PD-1/PD-L1 Blockade in Melanoma. Clin Ther 2015;37:764-782.
    • (2015) Clin Ther , vol.37 , pp. 764-782
    • Mahoney, K.M.1    Freeman, G.J.2    McDermott, D.F.3
  • 3
    • 84872339660 scopus 로고    scopus 로고
    • The price of tumor control: An analysis of rare side effects of anti-CTLA-4 therapy in metastatic melanoma from the ipilimumab network
    • Voskens CJ, Goldinger SM, Loquai C et al. The price of tumor control: an analysis of rare side effects of anti-CTLA-4 therapy in metastatic melanoma from the ipilimumab network. PLoS One 2013;8:e53745.
    • (2013) PLoS One , vol.8
    • Voskens, C.J.1    Goldinger, S.M.2    Loquai, C.3
  • 4
    • 84922738416 scopus 로고    scopus 로고
    • Peripheral neuropathy associated with ipilimumab: A report of 2 cases
    • Thaipisuttikul I, Chapman P, Avila EK. Peripheral neuropathy associated with ipilimumab: A report of 2 cases. J Immunother 2015;38:77-79.
    • (2015) J Immunother , vol.38 , pp. 77-79
    • Thaipisuttikul, I.1    Chapman, P.2    Avila, E.K.3
  • 5
    • 84883053806 scopus 로고    scopus 로고
    • Multifocal radiculoneuropathy during ipilimumab treatment of melanoma
    • Manousakis G, Koch J, Sommerville RB et al. Multifocal radiculoneuropathy during ipilimumab treatment of melanoma. Muscle Nerve 2013;48:440-444.
    • (2013) Muscle Nerve , vol.48 , pp. 440-444
    • Manousakis, G.1    Koch, J.2    Sommerville, R.B.3
  • 6
    • 84896934432 scopus 로고    scopus 로고
    • Atypical neurological complications of ipilimumab therapy in patients with metastatic melanoma
    • Liao B, Shroff S, Kamiya-Matsuoka C et al. Atypical neurological complications of ipilimumab therapy in patients with metastatic melanoma. Neuro Oncol 2014;16:589-593.
    • (2014) Neuro Oncol , vol.16 , pp. 589-593
    • Liao, B.1    Shroff, S.2    Kamiya-Matsuoka, C.3
  • 7
    • 79953300714 scopus 로고    scopus 로고
    • Anti-CTLA-4 antibodyinduced Guillain-Barré syndrome in a melanoma patient
    • Wilgenhof S, Neyns B. Anti-CTLA-4 antibodyinduced Guillain-Barré syndrome in a melanoma patient. Ann Oncol 2011;22:991-3.
    • (2011) Ann Oncol , vol.22 , pp. 991-993
    • Wilgenhof, S.1    Neyns, B.2
  • 8
    • 84875531958 scopus 로고    scopus 로고
    • Severe meningo-radiculo-neuritis associated with ipilimumab
    • Bompaire F, Mateus C, Taillia H et al. Severe meningo-radiculo-neuritis associated with ipilimumab. Invest New Drugs 2012;30:2407-2410.
    • (2012) Invest New Drugs , vol.30 , pp. 2407-2410
    • Bompaire, F.1    Mateus, C.2    Taillia, H.3
  • 9
    • 84952863785 scopus 로고    scopus 로고
    • Meningoencephalitis Following Ipilimumab Administration in Metastatic Melanoma
    • Stein MK, Summers BB, Wong CA et al. Meningoencephalitis Following Ipilimumab Administration in Metastatic Melanoma. Am J Med Sci 2015;350:512-513.
    • (2015) Am J Med Sci , vol.350 , pp. 512-513
    • Stein, M.K.1    Summers, B.B.2    Wong, C.A.3
  • 10
    • 84964294839 scopus 로고    scopus 로고
    • Ipilimumab-induced necrotic myelopathy in a patient with metastatic melanoma: A case report and review of literature
    • Abdallah A-O, Herlopian A, Ravilla R et al. Ipilimumab-induced necrotic myelopathy in a patient with metastatic melanoma: A case report and review of literature. J Oncol Pharm Pract 2016; 22:537-542.
    • (2016) J Oncol Pharm Pract , vol.22 , pp. 537-542
    • Abdallah, A.-O.1    Herlopian, A.2    Ravilla, R.3
  • 12
    • 84964389238 scopus 로고    scopus 로고
    • Neurological, respiratory, musculoskeletal, cardiac and ocular side-effects of anti-PD-1 therapy
    • Zimmer L, Goldinger SM, Hofmann L et al. Neurological, respiratory, musculoskeletal, cardiac and ocular side-effects of anti-PD-1 therapy. Eur J Cancer 2016;60:210-225.
    • (2016) Eur J Cancer , vol.60 , pp. 210-225
    • Zimmer, L.1    Goldinger, S.M.2    Hofmann, L.3
  • 13
    • 84962409041 scopus 로고    scopus 로고
    • Limbic encephalitis following immunotherapy against metastatic malignant melanoma
    • pii:bcr 2016215012
    • Salam S, Lavin T, Turan A. Limbic encephalitis following immunotherapy against metastatic malignant melanoma. BMJ Case Rep 2016;pii:bcr 2016215012.
    • (2016) BMJ Case Rep
    • Salam, S.1    Lavin, T.2    Turan, A.3
  • 14
    • 84962439197 scopus 로고    scopus 로고
    • Subacute CNS Demyelination after Treatment with Nivolumab for Melanoma
    • Maurice C, Schneider R, Kiehl T-R et al. Subacute CNS Demyelination after Treatment with Nivolumab for Melanoma. Cancer Immunol Res 2015;3:1299-1302.
    • (2015) Cancer Immunol Res , vol.3 , pp. 1299-1302
    • Maurice, C.1    Schneider, R.2    Kiehl, T.-R.3
  • 15
    • 84906794549 scopus 로고    scopus 로고
    • Lambrolizumab induced central nervous system (CNS) toxicity
    • Mandel JJ, Olar A, Aldape KD et al. Lambrolizumab induced central nervous system (CNS) toxicity. J Neurol Sci 2014;344:229-231.
    • (2014) J Neurol Sci , vol.344 , pp. 229-231
    • Mandel, J.J.1    Olar, A.2    Aldape, K.D.3
  • 16
    • 84981271733 scopus 로고    scopus 로고
    • Association of Autoimmune Encephalitis With Combined Immune Checkpoint Inhibitor Treatment for Metastatic Cancer
    • Williams TJ, Benavides DR, Patrice KA et al. Association of Autoimmune Encephalitis With Combined Immune Checkpoint Inhibitor Treatment for Metastatic Cancer. JAMA Neurol 2016; 73:928-933.
    • (2016) JAMA Neurol , vol.73 , pp. 928-933
    • Williams, T.J.1    Benavides, D.R.2    Patrice, K.A.3
  • 18
    • 0142009530 scopus 로고    scopus 로고
    • Paraneoplastic syndromes involving the nervous system
    • Darnell RB, Posner JB. Paraneoplastic syndromes involving the nervous system. N Engl J Med 2003;349:1543-1554.
    • (2003) N Engl J Med , vol.349 , pp. 1543-1554
    • Darnell, R.B.1    Posner, J.B.2
  • 19
    • 0035142625 scopus 로고    scopus 로고
    • Paraneoplastic brain stem encephalitis in a woman with anti-Ma2 antibody
    • Barnett M, Prosser J, Sutton I et al. Paraneoplastic brain stem encephalitis in a woman with anti-Ma2 antibody. J Neurol Neurosurg Psychiatry 2001; 70:222-225.
    • (2001) J Neurol Neurosurg Psychiatry , vol.70 , pp. 222-225
    • Barnett, M.1    Prosser, J.2    Sutton, I.3
  • 21
    • 85020943756 scopus 로고    scopus 로고
    • Merck
    • Available at, Accessed March 29
    • Merck. Prescribing Information for Keytruda 2014-2016. Available at https://www.merck.com/product/usa/pi_circulars/k/keytruda/keytruda_pi.pdf. Accessed March 29, 2017.
    • (2017) Prescribing Information for Keytruda 2014-2016
  • 22
    • 84884349954 scopus 로고    scopus 로고
    • Brainstem encephalitis: Etiologies, treatment, and predictors of outcome
    • Tan IL, Mowry EM, Steele SU et al. Brainstem encephalitis: Etiologies, treatment, and predictors of outcome. J Neurol 2013;260:2312-2319.
    • (2013) J Neurol , vol.260 , pp. 2312-2319
    • Tan, I.L.1    Mowry, E.M.2    Steele, S.U.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.